Corpus Intelligence IC Memo — PROVIDENCE CENTRALIA HOSPITAL 2026-04-26 05:23 UTC
IC Memo — PROVIDENCE CENTRALIA HOSPITAL
Investment Committee Memorandum | WA | 116 beds | Grade C | EBITDA uplift $17.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PROVIDENCE CENTRALIA HOSPITAL

CCN 500019 | LEWIS, WA | 116 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PROVIDENCE CENTRALIA HOSPITAL is a 116-bed suburban community hospital in LEWIS, WA with $240.6M in net patient revenue and a -0.5% operating margin. The hospital serves a payer mix of 31.9% Medicare, 1.7% Medicaid, and 66.4% commercial.

Thesis: Undervalued. Our ML models identify $17.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.5% to 6.8% (+736bps).

Net Revenue HCRIS$240.6M
Current EBITDA COMPUTED$-1.3M
Operating Margin COMPUTED-0.5%
Occupancy HCRIS56.0%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS23.5%
Distress Probability ML44.4%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
32
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -0.5% places it above the state median. Among 32 size-comparable peers (58-232 beds), the median margin is -10.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (58-232), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PROVIDENCE CENTRALIA HOSPITAL (Target)WA116$240.6M-0.5%
VIRGINIA MASON MEDICAL CENTERWA222$1.11B-23.2%
ST. JOSEPH MEDICAL CENTERWA208$750.0M1.9%
CENTRAL WASHINGTON HOSPITALWA176$550.9M-2.0%
YAKIMA VALLEY MEMORIAL HOSPITAWA208$522.3M-10.4%
LEGACY SALMON CREEK HOSPITALWA178$479.7M-5.2%
SWEDISH MEDICAL CENTER CHERRY WA181$463.4M-15.0%
PHD#1 DBA SKAGIT VALLEY HOSPIWA137$414.3M-17.9%
ST. JOHN MEDICAL CENTERWA122$335.0M-4.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $17.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.1M+210bp18mo
Cost to Collect4.5%2.5%$4.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.9M+122bp9mo
Clean Claim Rate88.0%96.0%$154K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.1M
Cost to Collect
$4.8M
Denial Rate Reduction
$4.8M
A/R Days Reduction
$2.9M
Clean Claim Rate
$154K
Total EBITDA Uplift$17.7M
Current EBITDA$-1.3M
+ RCM Uplift+$17.7M
Pro Forma EBITDA$16.5M
Current Margin-0.5%
Pro Forma Margin6.8%
WC Released (1x)$9.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.9M$168.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.9M$185.1M0.00x-100.0%
Bull Case9.0x11.0x$-1.7M$242.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.7M$264.4M0.00x-100.0%
Bear Case11.0x10.0x$-2.1M$80.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.1M$88.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 58-232 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-21.4% / P50=-10.4% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.